Menu Back toGlobal-Perspectives-on-Patient-Engagement

DIA 2018 Global Annual Meeting


Global Perspectives on Patient Engagement

    Session Chair(s)
      Jan  Geissler, MBA

      Jan Geissler, MBA

      • Patient Consultancy and Advocacy
      • Patvocates, Germany
    In Europe and North America, patient engagement in drug development is now expected, though not perfect. In this session, a panel of patient, industry, and regulator stakeholders will discuss the thinking and initiatives in other global regions to give patients a voice. We will look beyond Europe and North America to explore the thinking and efforts in other regions to engage patients in the medical product lifecycle. What efforts are underway or emerging to give patients a voice? What cultural, societal, and economic factors drive current thoughts and practices? Who are the influencers who are encouraging change? A diverse panel representing patient groups, regulators and industry from regions such as Asia and Latin America will talk about current experience, hopes, and aspirations for patient engagement worldwide.
    Learning Objective : Describe current practices for patient engagement in drug development and regulation in regions such as Asia and Latin America; Compare/contrast perspectives of patient, industry, and regulator stakeholders within these regions; Discuss cultural, societal, and other factors playing a role in views, practices, and emerging trends on patient engagement in these regions.
    Speaker(s)
      Rachel  Yang, MD, PhD

      Panelist

      Rachel Yang, MD, PhD

      • Director, International Affairs
      • Chinese Center For Rare Disorders (CORD), China
      Junko  Sato, PhD

      Panelist

      Junko Sato, PhD

      • Office Director, Office of International Cooperation
      • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
      Hee-sun  Kim

      Panelist

      Hee-sun Kim

      • Head of Clinical Development Center
      • Daewoong Pharmaceuticals, Korea, Republic of
      Julie Louise Gerberding, MD, MPH

      Panelist

      Julie Louise Gerberding, MD, MPH

      • Executive Vice President and Chief Patient Officer
      • Merck & Co., Inc., United States